TYLOX Drug Patent Profile
✉ Email this page to a colleague
When do Tylox patents expire, and when can generic versions of Tylox launch?
Tylox is a drug marketed by Janssen Pharms and Ortho Mcneil Pharm and is included in three NDAs.
The generic ingredient in TYLOX is acetaminophen; oxycodone hydrochloride; oxycodone terephthalate. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; oxycodone hydrochloride; oxycodone terephthalate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TYLOX?
- What are the global sales for TYLOX?
- What is Average Wholesale Price for TYLOX?
Summary for TYLOX
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 99 |
| DailyMed Link: | TYLOX at DailyMed |
US Patents and Regulatory Information for TYLOX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen Pharms | TYLOX | acetaminophen; oxycodone hydrochloride | CAPSULE;ORAL | 088790-001 | Dec 12, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ortho Mcneil Pharm | TYLOX | acetaminophen; oxycodone hydrochloride; oxycodone terephthalate | CAPSULE;ORAL | 085375-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ortho Mcneil Pharm | TYLOX-325 | acetaminophen; oxycodone hydrochloride | CAPSULE;ORAL | 088246-001 | Nov 8, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
